乌鸦传媒

<乌鸦传媒 class="page-title">Clinical Focus

PCSK9

<乌鸦传媒 class="page-description">

More in PCSK9

Who Should Get A Stress Test?

Andrew Perry, MD, asks an expert

Jun 13, 2018
image
ACC 2018: The Skeptical Cardiologist's Three Practice-Changing Presentations

Top picks by Anthony Pearson, MD

Jun 13, 2018
image
The Cardiologist's PCSK9 Script: 6 Months of Frustration

The 'honestly ridiculous' process William O'Neill, MD, faced for his own Rx

Jun 11, 2018
image
Plan Announced to Simplify PCSK9 Access

"Attestation" to replace one pharmacy benefit manager's extensive prior authorization for Praluent

Jun 11, 2018
image
Evolocumab Wins FDA Approval for Stand-Alone CVD Prevention

Will more patients now gain access to PCSK9 inhibitors?

Apr 12, 2018
image
Praluent Delivers CV Event Prevention in ODYSSEY

Second PCSK9 outcomes trial comes out like FOURIER -- but with mortality reduction

Apr 12, 2018
image

1.00 CME Credits
Improving Transitions of Care and Long-Term Outcomes for Patients With Spinal Muscular Atrophy (SMA)

3.00 CME Credits
Pain Management and the 2022 CDC Guideline for Prescribing Opioids for Pain

1.00 CME Credits
Engaging Older Adults in Vaccine Education: A Toolkit for Healthcare Providers

1.00 CME Credits
Uncomplicated Urinary Tract Infections: Leveraging Real-World Insights to Improve Patient Care

0.25 CME Credits
Utilizing Biomarkers and Prognostic Factors to Identify Rheumatoid Arthritis Patients at Risk for Poor Outcomes

0.50 CME Credits
Enhancing Vaccine Uptake in Older Adults: Supporting Conversations With Your Patients

0.50 CME Credits
The Latest Evidence for Integrating Biomarkers and Prognostic Factors Into Treatment Plans for Patients With Rheumatoid Arthritis

0.25 CME Credits
Leveraging the Latest Data to Guide Precision Medicine in Rheumatoid Arthritis